Connection
Kyle Rove to Androgen Antagonists
This is a "connection" page, showing publications Kyle Rove has written about Androgen Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.942 |
|
|
|
-
Rove KO, Crawford ED, Perachino M, Morote J, Klotz L, Lange PH, Andriole GL, Matsumoto AM, Taneja SS, Eisenberger MA, Reis LO. Maximal testosterone suppression in prostate cancer--free vs total testosterone. Urology. 2014 Jun; 83(6):1217-22.
Score: 0.421
-
Rove KO, Crawford ED. Traditional androgen ablation approaches to advanced prostate cancer: new insights. Can J Urol. 2014 Apr; 21(2 Supp 1):14-21.
Score: 0.420
-
Rove KO, Crawford ED. Androgen annihilation as a new therapeutic paradigm in advanced prostate cancer. Curr Opin Urol. 2013 May; 23(3):208-13.
Score: 0.395
-
Rove KO, Debruyne FM, Djavan B, Gomella LG, Koul HK, Lucia MS, Petrylak DP, Shore ND, Stone NN, Crawford ED. Role of testosterone in managing advanced prostate cancer. Urology. 2012 Oct; 80(4):754-62.
Score: 0.373
-
Crawford ED, Rove KO. Incomplete testosterone suppression in prostate cancer. N Engl J Med. 2010 Nov 11; 363(20):1976.
Score: 0.333